CA968710A - Anabolic compositions containing 19-nor-spiroxenone - Google Patents

Anabolic compositions containing 19-nor-spiroxenone

Info

Publication number
CA968710A
CA968710A CA123,798A CA123798A CA968710A CA 968710 A CA968710 A CA 968710A CA 123798 A CA123798 A CA 123798A CA 968710 A CA968710 A CA 968710A
Authority
CA
Canada
Prior art keywords
spiroxenone
anabolic
compositions containing
compositions
anabolic compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA123,798A
Other languages
English (en)
Other versions
CA123798S (fr
Inventor
Dolores J. Patanelli
Glen E. Arth
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Application granted granted Critical
Publication of CA968710A publication Critical patent/CA968710A/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/06—Anabolic agents
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/168—Steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Food Science & Technology (AREA)
  • Animal Husbandry (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Neurology (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
CA123,798A 1970-10-06 1971-09-27 Anabolic compositions containing 19-nor-spiroxenone Expired CA968710A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US7863670A 1970-10-06 1970-10-06

Publications (1)

Publication Number Publication Date
CA968710A true CA968710A (en) 1975-06-03

Family

ID=22145320

Family Applications (1)

Application Number Title Priority Date Filing Date
CA123,798A Expired CA968710A (en) 1970-10-06 1971-09-27 Anabolic compositions containing 19-nor-spiroxenone

Country Status (6)

Country Link
US (1) US3670079A (2)
AU (1) AU454533B2 (2)
CA (1) CA968710A (2)
DE (1) DE2149744A1 (2)
FR (1) FR2110251B1 (2)
GB (1) GB1350114A (2)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4013762A (en) * 1976-05-10 1977-03-22 Richardson-Merrell Inc. Growth promotion
ES2347027T3 (es) 1998-05-22 2010-10-22 The Board Of Trustees Of The Leland Stanford Junior University Moleculas bifuncionales y terapias basadas en las mismas.
IL152771A0 (en) * 2000-06-26 2003-06-24 Pfizer Prod Inc PYRROLO(2,3-d) PYRIMIDINE COMPOUNDS AS IMMUNOSUPPRESSIVE AGENTS
US6849638B2 (en) * 2001-04-30 2005-02-01 Bayer Pharmaceuticals Corporation 4-amino-5,6-substituted thiopheno [2,3-d] pyrimidines, pharmaceutical compositions containing the same, and their use in the treatment or prevention of pde7b-mediated diseases and conditions
JP4202250B2 (ja) 2001-07-25 2008-12-24 バイオマリン ファーマシューティカル インコーポレイテッド 血液脳関門輸送を調節するための組成物および方法
EP2671507A3 (en) 2005-04-28 2014-02-19 Proteus Digital Health, Inc. Pharma-informatics system
US9062126B2 (en) 2005-09-16 2015-06-23 Raptor Pharmaceuticals Inc. Compositions comprising receptor-associated protein (RAP) variants specific for CR-containing proteins and uses thereof
JP4884570B2 (ja) 2008-08-20 2012-02-29 ファイザー・インク ピロロ［２，３−ｄ］ピリミジン化合物
CA2752373C (en) 2009-02-20 2017-10-10 To-Bbb Holding B.V. Glutathione-based drug delivery system
IL255113B (en) 2009-05-06 2022-09-01 Laboratory Skin Care Inc Dermal delivery compositions comprising active agent-calcium phosphate particle complexes and methods of using the same
NL2022471B1 (en) 2019-01-29 2020-08-18 Vationpharma B V Solid state forms of oclacitinib

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3254074A (en) * 1962-04-25 1966-05-31 Merck & Co Inc Spiroxenones

Also Published As

Publication number Publication date
FR2110251A1 (2) 1972-06-02
GB1350114A (en) 1974-04-18
US3670079A (en) 1972-06-13
AU454533B2 (en) 1974-10-31
AU3384971A (en) 1973-03-29
DE2149744A1 (de) 1972-04-13
FR2110251B1 (2) 1975-06-06

Similar Documents

Publication Publication Date Title
CA970909A (en) Fabric-softener compositions
CA982542A (en) Compositions lubrifiantes
CA1010890A (en) Fluoroalkylsulfonamidoaryl compounds
CA968710A (en) Anabolic compositions containing 19-nor-spiroxenone
CA962267A (en) N-substituted-2-carboxy-1-azacy-clic compounds
CA971962A (en) 4-amino-2-styrylquinazoline compounds
CA928712A (en) Piperidylpropanol compounds
CA923895A (en) Thiazolylazo compounds
IL36967A (en) Compositions containing m-tyrisone
AU2640071A (en) Flame-retarded compositions
AU2843371A (en) Novel compounds
CA946741A (en) Labelled compositions
CA950466A (en) Bis-triazole compounds
AU2428071A (en) Compositions
CA959186A (en) Rubber-polyester compositions
CA847421A (en) Water-setable compositions
CA831496A (en) Wood-treatment compositions
AU453663B2 (en) Compositions containing n-dioctylethylene-triamines
AU2537671A (en) Composition
AU2523171A (en) Compositions containing n-dioctylethylene-triamines
AU458876B2 (en) Lysolecithin-containing compositions
CA852275A (en) Olyolefin compositions
CA848951A (en) Compositions anthelminthiques
AU447181B2 (en) Hydrocurable compositions
CA850066A (en) Veterinary compositions containing bottromycin